Investors Heavily Search McKesson Corporation (MCK): Here is What You Need to Know
McKesson (MCK) has been one of the stocks most watched by Zacks.com users lately. So, it is worth exploring what lies ahead for the stock.
McKesson Corporation (MCK) is Attracting Investor Attention: Here is What You Should Know
McKesson (MCK) has been one of the stocks most watched by Zacks.com users lately. So, it is worth exploring what lies ahead for the stock.
MCK Q3 Earnings & Sales Top Estimates, 2026 View Up
McKesson beats Q3 EPS and revenue estimates, raises fiscal 2026 guidance, and delivers broad-based growth led by oncology, specialty distribution and technology.
How McKesson Stock Surged 17% In A Day
McKesson (MCK), a prominent pharmaceutical wholesaler, experienced a stock increase of 17% during a high-volume trading session. The driver for this surge was a strong Q3 earnings report that surpassed expectations and, more importantly, a significant rise in the full-year 2026 adjusted EPS forecast.
Why McKesson (MCK) is a Top Growth Stock for the Long-Term
The Zacks Style Scores offers investors a way to easily find top-rated stocks based on their investing style. Here's why you should take advantage.
McKesson (MCK) Is Considered a Good Investment by Brokers: Is That True?
When deciding whether to buy, sell, or hold a stock, investors often rely on analyst recommendations. Media reports about rating changes by these brokerage-firm-employed (or sell-side) analysts often influence a stock's price, but are they really important?
McKesson Corporation (MCK) Q3 2026 Earnings Call Transcript
McKesson Corporation (MCK) Q3 2026 Earnings Call Transcript
McKesson (MCK) Reports Q3 Earnings: What Key Metrics Have to Say
While the top- and bottom-line numbers for McKesson (MCK) give a sense of how the business performed in the quarter ended December 2025, it could be worth looking at how some of its key metrics compare to Wall Street estimates and year-ago values.
McKesson (MCK) Q3 Earnings and Revenues Top Estimates
McKesson (MCK) came out with quarterly earnings of $9.34 per share, beating the Zacks Consensus Estimate of $9.31 per share. This compares to earnings of $8.03 per share a year ago.
Should You Buy, Sell, or Hold McKesson Before Q3 Earnings?
MCK approaches third-quarter earnings with strong growth expectations, but limited visibility on margins and investments keeps the outlook cautious.
Why the Market Dipped But McKesson (MCK) Gained Today
In the closing of the recent trading day, McKesson (MCK) stood at $831.21, denoting a +1.08% move from the preceding trading day.
Unlocking Q3 Potential of McKesson (MCK): Exploring Wall Street Estimates for Key Metrics
Looking beyond Wall Street's top-and-bottom-line estimate forecasts for McKesson (MCK), delve into some of its key metrics to gain a deeper insight into the company's potential performance for the quarter ended December 2025.
